Nectar Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nectar Lifesciences has submitted a certificate from its Registrar and Share Transfer Agent, KFin Technologies Limited, for the quarter ended March 31, 2026. The certificate confirms that all securities received from depository participants for dematerialization during the quarter were duly processed — either accepted or rejected — and that the corresponding shares have been listed on the stock exchanges (NSE and BSE). It also confirms that accepted physical certificates were mutilated, cancelled, and the depositories' names substituted as registered owners within the required timelines. This is a standard quarterly compliance filing with no new business or financial information disclosed.
This is a routine regulatory compliance filing and is unlikely to have any impact on the stock price or shareholder value. It simply confirms that the company's share transfer process is functioning as required by SEBI rules.